Home > Insider Trading > Filing (0001140361-14-018605)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219445	P Brian Mckeon	One Idexx Drive Westbrook ME 04092	Executive Vp & Cfo & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-30	4,800	$30.50	17,141	No	4	M	Direct
Common Stock	Disposition	2014-04-30	4,800	$126.05	12,341	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-04-30	4,800	$0.00	4,800	$30.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-05-18	No	4	M	Direct

Footnotes

The sale reported above was effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on 02/20/2014. The Plan covers certain stock options held by the reporting person that will expire in 2014 and 2015 and will permit the sale of the shares received upon the exercise of such stock options and the payment of the applicable exercise prices and taxes due upon the exercise of such stock options.
Grant of options to buy shares of common stock that vest one year from the date of grant (05/19/2005).